Fatty degeneration of the rotator cuff: pathogenesis, clinical implications, and future treatment

Chronic rotator cuff pathology is often complicated by fatty degeneration of the rotator cuff (FDRC) muscles, an insidious process associated with poor prognosis with or without surgical intervention. Currently there is no treatment for FDRC, and many studies have described a natural course for this...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jacob Bogdanov, BS, Rae Lan, BS, Timothy N. Chu, BS, Ioanna K. Bolia, MD, MS, PhD, Alexander E. Weber, MD, Frank A. Petrigliano, MD
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/0e83879e07e64546b010b5abf4207b3e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0e83879e07e64546b010b5abf4207b3e
record_format dspace
spelling oai:doaj.org-article:0e83879e07e64546b010b5abf4207b3e2021-11-22T04:31:42ZFatty degeneration of the rotator cuff: pathogenesis, clinical implications, and future treatment2666-639110.1016/j.xrrt.2021.05.006https://doaj.org/article/0e83879e07e64546b010b5abf4207b3e2021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2666639121000572https://doaj.org/toc/2666-6391Chronic rotator cuff pathology is often complicated by fatty degeneration of the rotator cuff (FDRC) muscles, an insidious process associated with poor prognosis with or without surgical intervention. Currently there is no treatment for FDRC, and many studies have described a natural course for this disease almost always resulting in further degeneration and morbidity. Recapitulating FDRC using animal injury models, and using imaging-based studies of human FDRC, the pathophysiology of this disease continues to be further characterized. Researchers studying mesenchymal stem cell–derived progenitor cells and known fibrogenic and adipogenic signaling pathways implicated in FDRC seek to clarify the underlying processes driving these changes. While new cell- and molecular-based therapies are being developed, currently the strongest available avenue for improved management of FDRC is the use of novel imaging techniques which allow for more accurate and personalized staging of fatty degeneration. This narrative review summarizes the evidence on the molecular and pathophysiologic mechanisms of FDRC and provides a clinical update on the diagnosis and management of this condition based on the existing knowledge. We also sought to examine the role of newer biologic therapies in the management of RC fatty degeneration and to identify areas of future research.Jacob Bogdanov, BSRae Lan, BSTimothy N. Chu, BSIoanna K. Bolia, MD, MS, PhDAlexander E. Weber, MDFrank A. Petrigliano, MDElsevierarticleFatty degenerationRotator cuffPathophysiologyStem cellsManagementSurgeryRD1-811ENJSES Reviews, Reports, and Techniques, Vol 1, Iss 4, Pp 301-308 (2021)
institution DOAJ
collection DOAJ
language EN
topic Fatty degeneration
Rotator cuff
Pathophysiology
Stem cells
Management
Surgery
RD1-811
spellingShingle Fatty degeneration
Rotator cuff
Pathophysiology
Stem cells
Management
Surgery
RD1-811
Jacob Bogdanov, BS
Rae Lan, BS
Timothy N. Chu, BS
Ioanna K. Bolia, MD, MS, PhD
Alexander E. Weber, MD
Frank A. Petrigliano, MD
Fatty degeneration of the rotator cuff: pathogenesis, clinical implications, and future treatment
description Chronic rotator cuff pathology is often complicated by fatty degeneration of the rotator cuff (FDRC) muscles, an insidious process associated with poor prognosis with or without surgical intervention. Currently there is no treatment for FDRC, and many studies have described a natural course for this disease almost always resulting in further degeneration and morbidity. Recapitulating FDRC using animal injury models, and using imaging-based studies of human FDRC, the pathophysiology of this disease continues to be further characterized. Researchers studying mesenchymal stem cell–derived progenitor cells and known fibrogenic and adipogenic signaling pathways implicated in FDRC seek to clarify the underlying processes driving these changes. While new cell- and molecular-based therapies are being developed, currently the strongest available avenue for improved management of FDRC is the use of novel imaging techniques which allow for more accurate and personalized staging of fatty degeneration. This narrative review summarizes the evidence on the molecular and pathophysiologic mechanisms of FDRC and provides a clinical update on the diagnosis and management of this condition based on the existing knowledge. We also sought to examine the role of newer biologic therapies in the management of RC fatty degeneration and to identify areas of future research.
format article
author Jacob Bogdanov, BS
Rae Lan, BS
Timothy N. Chu, BS
Ioanna K. Bolia, MD, MS, PhD
Alexander E. Weber, MD
Frank A. Petrigliano, MD
author_facet Jacob Bogdanov, BS
Rae Lan, BS
Timothy N. Chu, BS
Ioanna K. Bolia, MD, MS, PhD
Alexander E. Weber, MD
Frank A. Petrigliano, MD
author_sort Jacob Bogdanov, BS
title Fatty degeneration of the rotator cuff: pathogenesis, clinical implications, and future treatment
title_short Fatty degeneration of the rotator cuff: pathogenesis, clinical implications, and future treatment
title_full Fatty degeneration of the rotator cuff: pathogenesis, clinical implications, and future treatment
title_fullStr Fatty degeneration of the rotator cuff: pathogenesis, clinical implications, and future treatment
title_full_unstemmed Fatty degeneration of the rotator cuff: pathogenesis, clinical implications, and future treatment
title_sort fatty degeneration of the rotator cuff: pathogenesis, clinical implications, and future treatment
publisher Elsevier
publishDate 2021
url https://doaj.org/article/0e83879e07e64546b010b5abf4207b3e
work_keys_str_mv AT jacobbogdanovbs fattydegenerationoftherotatorcuffpathogenesisclinicalimplicationsandfuturetreatment
AT raelanbs fattydegenerationoftherotatorcuffpathogenesisclinicalimplicationsandfuturetreatment
AT timothynchubs fattydegenerationoftherotatorcuffpathogenesisclinicalimplicationsandfuturetreatment
AT ioannakboliamdmsphd fattydegenerationoftherotatorcuffpathogenesisclinicalimplicationsandfuturetreatment
AT alexanderewebermd fattydegenerationoftherotatorcuffpathogenesisclinicalimplicationsandfuturetreatment
AT frankapetriglianomd fattydegenerationoftherotatorcuffpathogenesisclinicalimplicationsandfuturetreatment
_version_ 1718418144723206144